Health Economic Evaluations for Alzheimer’s Disease: Pathophysiology, Diagnosis and Pharmacological Approaches

References (66)

1. 1 “Mini-mental state” [DOI]
2. 2 The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment [DOI]
3. 3 NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease [DOI]
4. 4 The Cholinergic Hypothesis of Geriatric Memory Dysfunction [DOI]
5. 5 The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods [DOI]
6. 6 Amyloid-β and Tau [DOI]
7. 7 Amyloid Precursor Protein Processing and Alzheimer's Disease [DOI]
8. 8 Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report [DOI]
9. 9 Alzheimer's disease: Targeting the Cholinergic System [DOI]
10. 10 Human Memory and the Cholinergic System [DOI]
11. 11 The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development [DOI]
12. 12 Role of Glutamate and NMDA Receptors in Alzheimer’s Disease [DOI]
13. 13 Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI) [DOI]
14. 14 Alzheimer’s disease prevention: from risk factors to early intervention [DOI]
15. 15 Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia [DOI]
16. 16 Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association [DOI]
17. 17 The Role of NMDA Receptors in Alzheimer’s Disease [DOI]
18. 18 The GPCOG: A New Screening Test for Dementia Designed for General Practice [DOI]
19. 19 Galantamine [DOI]
20. 20 Drugs with anticholinergic effects and cognitive impairment, falls and all‐cause mortality in older adults: A systematic review and meta‐analysis [DOI]
21. 21 Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research [DOI]
22. 22 Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review [DOI]
23. 23 Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies [DOI]
24. 24 Pre-Clinical Detection of Alzheimer's Disease Using FDG-PET, with or without Amyloid Imaging [DOI]
25. 25 Montreal Cognitive Assessment Memory Index Score (MoCA‐MIS) as a Predictor of Conversion from Mild Cognitive Impairment to A lzheimer's Disease [DOI]
26. 26 Role of structural MRI in Alzheimer's disease [DOI]
27. 27 Tacrine: First Drug Approved for Alzheimer's Disease [DOI]
28. 28 Early detection of Alzheimer's disease using PiB and FDG PET [DOI]
29. 29 Neurofibrillary Tangles and Alzheimer’s Disease [DOI]
30. 30 Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimer Disease [DOI]
31. 31 Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment [DOI]
32. 32 DEFINING DISEASE MODIFYING THERAPY FOR ALZHEIMER’S DISEASE [DOI]
33. 33 ApoE and Neurodegenerative Diseases in Aging [DOI]
34. 34 Understanding the Role of ApoE Fragments in Alzheimer’s Disease [DOI]
35. 35 The diagnostic accuracy of the Ascertain Dementia 8 questionnaire for detecting cognitive impairment in primary care in the community, clinics and hospitals: a systematic review and meta-analysis [DOI]
36. 36 The Mini-Mental State Examination in Alzheimer’s Disease and Multi-Infarct Dementia [DOI]
37. 37 Incidence of Alzheimer′s disease in India: A 10 years follow-up study [DOI]
38. 38 NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease [DOI]
39. 39 Tacrine for Alzheimer's disease [DOI]
40. 40 Rivastigmine in the treatment of patients with Alzheimer's disease [DOI]
41. 41 The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease [DOI]
42. 42 Amyloid Imaging: Poised for Integration into Medical Practice [DOI]
43. 43 Alzheimer's Disease Effects on Semantic Memory: Loss of Structure or Impaired Processing? [DOI]
44. 44 An Overview of the Etiology, Diagnosis, and Treatment of Alzheimer Disease [DOI]
45. 45 Predictive factors for rapid loss on the mini-mental state examination in Alzheimer's disease.
46. 46 Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease [DOI]
47. 47 Rivastigmine in Alzheimer's disease: Cognitive function and quality of life.
48. 48 Clinical evaluation of the ICD-10 criteria for vascular dementia [DOI]
49. 49 Science [DOI]
50. 50 The Neuropsychological Profile of Alzheimer Disease [DOI]
51. 51 Home visits: a strategy to improve newborn survival - Authors' reply [DOI]
52. 52 Suspending OpenMP Tasks on Asynchronous Events: Extending the Taskwait Construct [DOI]
53. 53 Comprehensive Review on Alzheimer’s Disease: Causes and Treatment [DOI]
54. 54 Alzheimer's disease [DOI]
55. 55 Alzheimer's disease [DOI]
56. 56 Clinical trials of new drugs for Alzheimer disease [DOI]
57. 57 Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias [DOI]
58. 58 Alzheimer's disease: Recent treatment strategies [DOI]
59. 59 Defective mitophagy in Alzheimer’s disease [DOI]
60. 60 Ubiquitin-mediated regulation of autophagy [DOI]
61. 61 Changing demography and the challenge of dementia in India [DOI]
62. 62 Alzheimer's Disease [DOI]
63. 63 The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applications [DOI]
64. 64 A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice [DOI]
65. 65 International Statistical Classification of Diseases and Related Health Problems [DOI]
66. 66 Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI) [DOI]

Cited by 0

No indexed citations yet.

Related research

• Regions and Sub-regions Dysfunctions in Alzheimer’s during Rest — shares topic coverage
• An Overview on the Aetiology and Treatment of Alzheimer's Disease — shares topic coverage
• Dementia Diagnosis and Alternate Treatment: A Recent Update on Treatment Options — shares topic coverage
• The Brain Cholinergic System in Neurodegenerative Diseases — shares topic coverage
• Synthesis and Development of BACE 1 Inhibitor for Alzheimer’s Diseases from Medicinal Plants — shares topic coverage